Abaxis (NAS: ABAX) is expected to report Q3 earnings around Jan. 24. Here's what Wall Street wants to see: Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict ...

Abaxis, Inc. ABAX has been gaining investor confidence on consistently positive results. Over the past six months, the company’s share price has outperformed its industry. The stock has gained 67.8% ...

UNION CITY, Calif., Oct. 31, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Company has signed ...

Abaxis is in the final stages of testing a new software product it calls FUSE, Wood said, which is a web-based package that enables two-way data sharing between its instruments and vet ...

Abaxis (Nasdaq: ABAX) is expected to report Q4 earnings on April 25. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year quarter, average ...

(Reuters) - Top animal health company Zoetis Inc (ZTS.N) will buy Abaxis Inc (ABAX.O) for $1.9 billion (£1.4 billion), looking to capture a bigger slice of the fast-growing market for diagnostics ...

In this series, we measure how swiftly a company turns cash into goods or services and back into cash. We'll use a quick, relatively foolproof tool known as the cash conversion cycle, or CCC for short ...

On Nov 20, Zacks Investment Research upgraded home health and hospice care provider Abaxis Inc. (ABAX) to a Zacks Rank #2 (Buy). We are impressed with Abaxis' encouraging second-quarter fiscal 2015 ...

Looking at the universe of stocks we cover at Dividend Channel, on 2/27/15, Abaxis, Inc. (NASD: ABAX), Teleflex Incorporated (NYSE: TFX), and Chemed Corp (NYSE: CHE) will all trade ex-dividend for ...

Simply sign up to the US & Canadian companies myFT Digest -- delivered directly to your inbox. Animal health group Zoetis has agreed to purchase Abaxis, a maker of portable blood diagnostic systems ...